These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19915170)

  • 1. The use of baseline covariates in crossover studies.
    Kenward MG; Roger JH
    Biostatistics; 2010 Jan; 11(1):1-17. PubMed ID: 19915170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hierarchical testing of multiple endpoints in group-sequential trials.
    Glimm E; Maurer W; Bretz F
    Stat Med; 2010 Jan; 29(2):219-28. PubMed ID: 19827011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The population risk as an explanatory variable in research synthesis of clinical trials.
    McIntosh MW
    Stat Med; 1996 Aug; 15(16):1713-28. PubMed ID: 8870154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical models for heart rate correction of the QT interval.
    Ring A
    Stat Med; 2010 Mar; 29(7-8):786-96. PubMed ID: 20213712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residuals and outliers in replicate design crossover studies.
    Schall R; Endrenyi L; Ring A
    J Biopharm Stat; 2010 Jul; 20(4):835-49. PubMed ID: 20496209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of two-stage test statistic in the two-period crossover trials.
    Wang SJ; Hung HM
    Biometrics; 1997 Sep; 53(3):1081-91. PubMed ID: 9333341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple analysis of crossover studies with one-group interaction.
    Cleophas TJ
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):322-7. PubMed ID: 7582382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change from baseline and analysis of covariance revisited.
    Senn S
    Stat Med; 2006 Dec; 25(24):4334-44. PubMed ID: 16921578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exhaled nitric oxide and bronchial wall thickening in asthmatics during and after acute exacerbation: evidence of bronchial wall remodeling.
    Ketai L; Harkins M; Fiato KL; Iwamoto GK
    J Asthma; 2005 Oct; 42(8):667-71. PubMed ID: 16266958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of covariance in parallel-group clinical trials with pretreatment baselines.
    Crager MR
    Biometrics; 1987 Dec; 43(4):895-901. PubMed ID: 3427174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global tests for combination drug studies in factorial trials.
    Hung HM
    Stat Med; 1996 Feb; 15(3):233-47. PubMed ID: 8643882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On planning the number of controls in cross-sectional studies using previous studies: an application in occupational epidemiology.
    Wild P; Jovanovic B; Massin N
    J Epidemiol Biostat; 1999; 4(2):93-9. PubMed ID: 10619056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exhaled carbon monoxide in asthmatic adults with bronchial reactivity: a prospective study.
    Pogson ZE; Antoniak MD; Mckeever TM; Lewis SA; Britton JR; Fogarty AW
    J Asthma; 2009 Sep; 46(7):665-9. PubMed ID: 19728202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical perspective on adjusting for center effect in a 2 x 2 crossover design with application to clinical trials.
    Yue LQ
    J Biopharm Stat; 2000 Nov; 10(4):559-71. PubMed ID: 11104393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the estimation of change from baseline in a continuous outcome measure in the clinical trial setting.
    Mayer-Hamblett N; Kronmal RA
    Contemp Clin Trials; 2005 Feb; 26(1):2-16. PubMed ID: 15837448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure.
    Tobin MD; Sheehan NA; Scurrah KJ; Burton PR
    Stat Med; 2005 Oct; 24(19):2911-35. PubMed ID: 16152135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small sample inference for fixed effects from restricted maximum likelihood.
    Kenward MG; Roger JH
    Biometrics; 1997 Sep; 53(3):983-97. PubMed ID: 9333350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for analyzing multilevel cluster-randomized studies with binary outcomes collected at varying intervals of time.
    Olsen MK; DeLong ER; Oddone EZ; Bosworth HB
    Stat Med; 2008 Dec; 27(29):6055-71. PubMed ID: 18825655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical methods for active extension trials.
    Hu Z; Follmann D
    Stat Med; 2007 May; 26(12):2433-48. PubMed ID: 17066400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.